Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
260.75
-0.83 (-0.32%)
At close: Jun 26, 2026, 4:00 PM EDT
261.00
+0.25 (0.10%)
After-hours: Jun 26, 2026, 6:16 PM EDT
Ascendis Pharma Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Ascendis Pharma stock have an average target of 300.8, with a low estimate of 255 and a high estimate of 355. The average target predicts an increase of 15.36% from the current stock price of 260.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ascendis Pharma stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|
| Strong Buy | 3 | 13 | 14 |
| Buy | 1 | 4 | 4 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 4 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $450 → $326 | Buy | Maintains | $450 → $326 | +25.02% | Jun 17, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $288 | Buy | Maintains | $288 | +10.45% | Jun 16, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $262 | Buy | Reiterates | $262 | +0.48% | Jun 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $273 | Buy | Maintains | $273 | +4.70% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
1.34B
from 720.13M
Increased by 85.76%
Revenue Next Year
1.94B
from 1.34B
Increased by 45.17%
EPS This Year
11.45
EPS Next Year
9.43
from 11.45
Decreased by -17.60%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | 2.3B | |
| Avg | 1.3B | 1.9B | |
| Low | 1.3B | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 115.3% | 71.9% | |
| Avg | 85.8% | 45.2% | |
| Low | 75.0% | 28.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.76 | 11.70 | |
| Avg | 11.45 | 9.43 | |
| Low | 2.13 | 7.56 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | 2.2% | 64.3% |
| Avg | -17.6% | 37.6% |
| Low | -34.0% | 8.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.